检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王东浩[1]
机构地区:[1]天津医科大学附属肿瘤医院ICU,300060
出 处:《中国急救医学》2007年第1期15-17,共3页Chinese Journal of Critical Care Medicine
摘 要:目的回顾性研究乳酸清除率与重度脓毒症患者预后的相关性。方法收集247例重度脓毒症患者入ICU后的APACHEⅡ评分、脓毒症休克发生率、入ICU 12 h后乳酸清除率及患者转归。分别将病例分成存活组和死亡组,高乳酸清除率组和低乳酸清除率组,比较其差异的统计学意义。结果各组年龄、性别、APACHEⅡ评分和初始血乳酸浓度比较差异均无统计学意义(P>0.05)。存活组脓毒症休克发生率明显低于死亡组(31.03% vs 83.33%,P<0.01),乳酸清除率明显高于死亡组[(31.86±16.34)% vs(14.77±10.35)%,P<0.01];高乳酸清除率组脓毒症休克发生率、病死率均明显低于低乳酸清除率组(29.45% vs 90.48%,30.67% vs 85.71%,P均<0.01)。APACHEⅡ评分与病死率无相关性。结论乳酸清除率可用于早期评估重度脓毒症患者的预后转归。Objective To retrospectively analyze the correlation between the prognosis and the lactate clearance rate in severe sepsis patients. Methods The data of 247 severe sepsis patients were col- lected, including the score of APACHE Ⅱ after admission to ICU, the morbidity of septic shock, the lactate clearance rate after 12 hours in ICU and the patients' prognosis. A total of 247 cases were divided into survival group and dead group, low lactate clearance rate group and high lactate clearance rate group, and the differences between them were compared for statistical significance. Results There were no differences in age, sex, the score of APACHE Ⅱ after admission to ICU and the initial blood concentration of lactate ( P 〉 0.05). In survival group, the morbidity of septic shock was significantly less ( 31.03 % vs 83.33% ,P 〈0.01), but the lactate clearance rate was significantly higher than in dead group[ ( 31.86 ± 16. 34}% vs ( 14.77± 10.35)%, P 〈 0.01 ] ; In high lactate clearance rate group, the morbidity of septic shock and the mortality were significantly lower than in the low lactate clearance rate group( 29.45% vs 90.48%, P 〈0.01 ; 30.67% vs 85.71%, P 〈0.01 }. ConcIusion The lactate clearance rate can predict the prognosis of severe sepsis even in early phase.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117